1. |
Garrod AG. Inborn error of metabolism. Oxford: Oxford University Press; 1909.
|
2. |
Scriver CR, Beaudet al, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease, 8th ed. New York: McGraw-Hill; 2001.
|
3. |
Clarke JT, editor. A clinical guide to inherited metabolic diseases, 2nd ed. United Kingdom: Cambridge University Press; 2002.
|
4. |
Shevell M, Ashwal S, Donley D, Flint J, Gingold M, Hirtz D, et al.
Practice parameter: Evaluation of the child with global developmental
delay: Report of the quality standards subcommittee of the American
Academy of Neurology and the practice committee of the child neurology
society. Neurology 2003;60:367-80.
|
5. |
Burton BK. Inborn errors of metabolism in infancy: A guide to diagnosis. Pediatrics 1998;102:e63. |
6. |
Salem
M. Metabolic ataxias. In: Vinken PJ, Bruyn GW, editors. Handbook of
clinical neurology. Vol 21. Amsterdam: North-Holland; 1975. p. 573-85. |
7. |
Barth PG, Hoffmann GF, Jaeken J, Lehnert W, Hanefeld F, van Gennip AH, et al. L2 hydroxy glutaric academia: A novel inherited neurometabolic disease. Ann Neurol 1992;32:66-71. |
8. |
Topcu M, Aydin OF, Yalcinkaya C, Haliloπlu G, Aysun S, Anlar B, et al. L-2-Hydroxyglutaric aciduria: A report of 29 patients. Turk J Pediatr 2005;47:1-7.
|
9. |
Parker CC, Evans OB. Metabolic disorders causing childhood ataxia. Semin Pediatr Neurol 2003;10:193-9. |
10. |
Gascon
GG, Ozand PT, Brismar J. Movement disorders in childhood organic
acidurias: Clinical neuroimaging and biochemical correlations. Brain
Dev 1994;16:94-103.
|
11. |
Uc EY Rodnitzky RL. Childhood dystonia. Semin Pediatr Neurol 2003;10:52-61.
|
12. |
Superti-Furga
A. Hoffman GF. Glutaric aciduria type 1 (Glutaryl CoA-dehydrogenase
deficiency): Advances and unanswered questions. Eur J Pediatr
1997;157:821. |
13. |
Heidenriech R, Natowics M, Hainline BE, Berman P, Kelley RI, Hillman RE, et al.
Acute extrapyramidal syndrome in methyl malonic academia: "Metabolic
stroke" involving the globus pallidus. J Pediatr 1988;113:1022-7. |
14. |
Puig
JG, Torres RJ, Mateos FA, Arcas J, Buρo A, Pascual-Castroviejo I. The
spectrum of HGPRT deficiency: Clinical experience based on 20 patients
from 16 Spanish families. Adv Exp Med Biol 1998;421:25-9. |
15. |
Segawa
M, Hosaka A, Miyagawa F, Nomura Y, Imai H. Hereditary progressive
dystonia with marked diurnal fluctuation. Adv Neurol 1976;14:215-33. |
16. |
Imrie J, Vijayaraghaven S, Whitehouse C, Harris S, Heptinstall L, Church H, et al. Niemann-pick type C in adults. J Inherit Metab Dis 2002;25:491-500.
|
17. |
Joseph
KA, Van ger pen MW, Van Gerpen JA. Adult onset nieman-pick disease type
C presenting with psychosis. J Neurol Neurosurg Psychiatry
2003;74:528-9.
|
18. |
Meek
D, Wolf LS, Anderman E, Anderman F. Juvenile progressive dystonia: A
new phenotype of GM2 gangliosidosis. Ann Neurol 1984;15:348-52. |
19. |
Hardie
RJ, Young EP, Morgan-Hughes JA. Hexosaminidase A deficiency presenting
as juvenile progressive dystonia. J Neurol Neurosurg Psychiatry
1988;51:446-59.
|
20. |
Roze E, Paschke E, Lopez N, Eck T, Yoshida K, Maurel-Ollivier A, et al. Dystonia and Parkinsonism in GM1 type 3 gangliosidosis. Mov Disord 2005;20:1366-9. |
21. |
Muthane UB, Chikkabasaviah Y, Kaneski C, Shankar SK, Narayanappa G, Christopher R, et al.
Clinical features of adult GM1 gangliosidosis: Report of three Indian
patients and review of 40 cases. Mov Disord 2004;19:1334-41. |
22. |
DiMauro
S, Tonin P, Servidei S. Metabolic myopathies. In: Vinken PJ, Bruyn GW,
editors. Handbook of clinical neurology, vol 18. Amsterdam: North
Holland; 1992. p. 479-526. |
23. |
Al-Khatib A, Dulaney E, Katirji B. Ischemic forearm exercise test. In: Katriji B, et al, editors. Neuromuscular disorders in clinical practice. Boston: Butterworth-Heinemann; 2002. p. 74-9. |
24. |
Grey
RG, Preece MA, Green SH, Whitehouse W, Winer J, Green A. Inborn error
of metabolism as a cause of neurological disease in adults: An approach
to investigation. J Neurol Neurosurg Psychiatry 2000;69:5-12. |
25. |
Bosch EP, Hart MN. Late adult onset metachromatic Leukodystrophy. Arch Neurol 1978;35:475. |
26. |
Boumann
N, Masson M, Casseau V, Lefevre M, Herschkowitz N, Turpin JC. Adult
forms of metachromatic leukodystrophy: Clinical and biochemical
approach. Dev Neurosci 1991;13:211-5.
|
27. |
Dimango
EP, Lowe JE, Snodgrass PJ, Jones JD. Ornithine carbamylase deficiency:
A cause of bizarre behaviour in a man. N Engl J Med 1986;315:744-7.
|
28. |
Finkelstein
JE, Hauser ER, Leonard CO, Brusilow SW. Late onset ornithine
transcarbamylase deficiency in male patients. J Pediatr
1990;117:897-902. |
29. |
Sovik
O. Inborn errors of aminoacid and fatty acid metabolism with
hypoglycemia as a major clinical manifestation. Acta Paediatr Scand
1989;78:161-70.
|
30. |
Saudubury JM, de Lonlay P, Touati G, Martin D, Nassogne MC, Castelnau P, et al. Genetic hypoglycaemia in infancy and childhood: Pathophysiology and diagnosis. J Inherit Metab Dis 2000;23:197-214.
|
31. |
Robinson
BH. Lactic acidemia: Biochemical, clinical and genetic considerations.
In: Harris H, Hirschborn K, editors. Advances in human genetics. New
York: Plenum; 1989. p. 151-70.
|
32. |
Saudubray JM, Specola N, Middleton B. Hyperketotic states due to inherited defects of ketolysis. Enzyme 1987;38:89-90.
|
33. |
Chace
DH, Kalas TA, Naylor EW. Use of tandem mass spectrometry for
multi-analytic screening of dried blood specimens for newborns. Clin
Chem 2003;49:1797-817.
|
34. |
Schulze
A, Lindner M, Kohlmuller D, Olgemuller K, Mayatepek E, Hoffmann GF.
Expanded newborn screening for inborn errors of metabolism by
electrospray ionisation-tandem mass spectrometry: Results, outcome, and
implications. Pediatrics 2003;111:1399-406.
|
35. |
Pandor
A, Eastham J, Beverley C, Chilcott J, Paisley S. Clinical effectiveness
and cost-effectiveness of neonatal screening for inborn errors of
metabolism using tandem mass spectrometry: A systematic review. Health
Technol Assess 2004;8:iii1-12.
|
36. |
Naidu
S, Moser HW. Value of neuroimaging in metabolic diseases affecting the
central nervous system. AJNR Am J Neuroradiol 1991;12:413-6. |
37. |
Bindu PS, Sinha S, Taly AB, Chandrasekhar HS, Christopher R, Arunodaya GR, et al. Extensive cortical magnetic resonance signal change in proximal urea cycle disorder. J Child Neurol 2007;22:238-9.
|
38. |
Shaw
DW, Maravilla KR, Weinberger E, Garretson J, Trahms CM, Scott CR. MR
imaging of phenylketonuria. AJNR Am J Neuroradiol 1991;12:403-6. |
39. |
Van
der Knaap MS, Valk J. MR imaging in phenyl ketonuria In: Magnetic
resonance of myelin, myelination and myelin disorders. 2nd ed. Berlin:
Springer-Verlag; 1995. p. 31-52.
|
40. |
Brismar
J, Aqueel A, Brismar G, Coates R, Gascon G, Ozand P. Maple syrup urine
disease: Findings on CT and MR scans of the brain in 10 infants. AJNR
Am J Neuroradiol 1990;11:1219-28.
|
41. |
Bindu
PS, Shehanaz KE, Christopher R, Pal PK, Ravishankar S. Intermediate
maple syrup urine disease: Neuroimaging observations in 3 patients from
South India. J Child Neurol 2007;22:911-3. |
42. |
Twomey EL, Naughten ER, Donoghue VB, Ryan S. Neuroimaging findings in glutaric aciduria type 1. Pediatr Radiol 2003;33:823-30.
|
43. |
Brismar
J, Ozand PT. CT and MR of the brain in glutaric acidemia type I: A
review of 59 published cases and a report of 5 new patients. AJNR Am J
Neuroradiol 1995;16:675-83. |
44. |
Neumaier-Probst
E, Harting I, Seitz A, Ding C, Kolker S. Neuroradiological findings in
glutaric aciduria type I (glutaryl-CoA dehydrogenase deficiency). J
Inherit Metab Dis 2004;27:869-76. |
45. |
Andreula CF, De Blasi R, Carella A. CT and MR studies of methyl malonic acidemia. AJNR Am J Neuroradiol 1991;12:410-2.
|
46. |
Korf
B, Wallman JK, Levy HL. Bilateral lucency of the globus pallidus
complicating methyl malonic academia. Ann Neurol 1986;20:364-6. |
47. |
Peters
C. Effective treatment of the central nervous system in lysosomal
storage diseases: Save that brain. J Lab Clin Med 2003;142:361-3.
|